The Future of Biomarkers in Neurodegeneration
Neurodegenerative disease research is entering a transformative era, fueled by rapid advancements in biomarkers, digital health technologies, and precision medicine. This workshop will explore how emerging biomarkers are redefining clinical research by accelerating diagnosis, improving trial design, and enabling more personalized approaches to patient care.
Participants will gain valuable insights into how biological, digital, and wearable markers are shaping the future of neurodegeneration research through expert presentations.
This session is designed for clinicians, researchers, and industry professionals. It will showcase real-world applications, challenges, and opportunities as we move toward more precise, data-driven approaches in the development of treatments for neurodegenerative diseases and beyond.
Event Details: Free Half-day Workshop
Date: 6 May 2026
Location: Clinilabs Europe Headquarters, Scientific Innovation Park, Basel, Switzerland | Conference Room M9
Format: Educational Workshop from 9:00 to 12:00 CET, followed by Lunch Networking Session
Agenda
09:00 – 09:30 | Welcome & Breakfast
09:30 – 09:35 | Introduction
09:30 – 10:00 | From Signal to Endpoint: Making Digital Measures Count in Drug Development
- Speaker: Bill Byrom, VP Product Intelligence and Positioning, Signant Health
10:00 – 10:30 | Wearable Medical Devices for Parkinson’s Disease: From High-Quality Data to Reliable Digital Biomarkers for Precision Neurology
- Speaker: Chiara Capra, Co-Founder & CEO @LIFE Neurotech & CPO @Sense4Care
10:30 – 10:45 | Coffee Break
10:45 – 11:15 | Accelerating Neurodegeneration Trials with Remote, Speech-Based Biomarkers
- Speaker: Nicklas Linz, CEO and Co-founder of Ki elements
11:15 – 11:55 | TBD
- Speaker: TBD
11:55 – 12:00 | Closing Remarks
- Key Takeaways
12:00 – 13:30 | Networking Lunch
